de Verneuil Vanina — SEC insider filings
SEC reporting owner CIK 2036234. 10 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-11-05 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 10 filings — 49,498 shares, $453,027 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 13,700 shares @ $9.82 ($134,534) in Vir Biotechnology, Inc., filed 2026-02-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | EVP, General Counsel, Corp Sec | 10 | — | 13 legs · 49,498 sh · $453,027 | 4 |
Insider filings — de Verneuil Vanina
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 1,343 @ $11.33 · Sale (S): 2,407 @ $11.10 | EDGAR |
| 2026-02-26 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 3,117 @ $9.53 · Sale (S): 13,700 @ $9.82 | EDGAR |
| 2026-02-24 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 55,000 @ $0 · Sale (S): 4,445 @ $7.45 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 2,385 @ $5.16 | EDGAR |
| 2025-11-04 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 1,365 @ $5.86 | EDGAR |
| 2025-02-27 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 7,373 @ $9.14 | EDGAR |
| 2025-02-25 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 35,000 @ $0 · Sale (S): 5,140 @ $9.45 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 76 @ $8.22 | EDGAR |
| 2024-11-07 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 4,397 @ $10.11 | EDGAR |
| 2024-11-05 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 1,403 @ $7.20 · Sale (S): 2,347 @ $9.47 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2036234 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs